|
1
|
Kaukonen KM, Bailey M, Pilcher D, Cooper
DJ and Bellomo R: Systemic inflammatory response syndrome criteria
in defining severe sepsis. New Engl J Med. 372:1629–1638. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thimmulappa RK, Lee H, Rangasamy T, Reddy
SP, Yamamoto M, Kensler TW and Biswal S: Nrf2 is a critical
regulator of the innate immune response and survival during
experimental sepsis. J Clin Invest. 116:984–995. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fleischmann C, Thomas-Rueddel DO, Hartmann
M, Hartog CS, Welte T, Heublein S, Dennler U and Reinhart K:
Hospital incidence and mortality rates of sepsis. Dtsch Arztebl
Int. 113:159–166. 2016.PubMed/NCBI
|
|
4
|
Rhodes A, Evans LE, Alhazzani W, Levy MM,
Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally
ME, et al: Surviving sepsis campaign: International guidelines for
management of sepsis and septic shock: 2016. Crit Care Med.
45:486–552. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hunter JG, Pritchett C, Pandya D, Cripps A
and Langford R: Sim-sepsis: Improving sepsis treatment in the
emergency department? BMJ Simul Technol Enhanc Learn.
2018:bmjstel2018.
|
|
6
|
Fay KT, Ford ML and Coopersmith CM: The
intestinal micro-environment in sepsis. Biochim Biophysica Acta Mol
Basis Dis. 1863:2574–2583. 2017. View Article : Google Scholar
|
|
7
|
Yoseph BP, Klingensmith NJ, Liang Z, Breed
ER, Burd EM, Mittal R, Dominguez JA, Petrie B, Ford ML and
Coopersmith CM: Mechanisms of intestinal barrier dysfunction in
sepsis. Shock. 46:52–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gill SE, Rohan M and Mehta S: Role of
pulmonary microvascular endothelial cell apoptosis in murine
sepsis-induced lung injury in vivo. Respir Res. 16:1–13. 2015.
View Article : Google Scholar
|
|
9
|
Luan Y, Yao Y, Xiao X and Sheng Z:
Insights into the apoptotic death of immune cells in sepsis. J
Interferon Cytokine Res. 35:17–22. 2015. View Article : Google Scholar :
|
|
10
|
Delano MJ and Ward PA: Sepsis-induced
immune dysfunction: Can immune therapies reduce mortality? J Clin
Invest. 126:23–21. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fang W and Bartel DP: The menu of features
that define primary microRNAs and enable de novo design of microRNA
genes. Mol Cell. 60:131–145. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giza DE, Fuentesmattei E, Bullock MD,
Tudor S, Goblirsch MJ, Fabbri M, Lupu F, Yeung SJ, Vasilescu C and
Calin GA: Cellular and viral microRNAs in sepsis: Mechanisms of
action and clinical applications. Cell Death Differ. 23:1906–1918.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao M, Wang X, Zhang X, Ha T, Ma H, Liu L,
Kalbfleisch JH, Gao X, Kao RL and Williams DL: Attenuation of
cardiac dysfunction in polymicrobial sepsis by MicroRNA-146a is
mediated via targeting of IRAK1 and TRAF6 expression. J Immunol.
195:672–682. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Roderburg C, Luedde M, Vargas Cardenas DV,
Vucur M, Scholten D, Frey N, Koch A, Trautwein C, Tacke F and
Luedde T: Circulating MicroRNA-150 serum levels predict survival in
patients with critical illness and sepsis. PLoS One. 8:e546122013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tacke F, Roderburg C, Benz F, Cardenas DV,
Luedde M, Hippe HJ, Frey N, Vucur M, Gautheron J, Koch A, et al:
Levels of circulating miR-133a are elevated in sepsis and predict
mortality in critically ill patients. Crit Care Med. 42:1096–1104.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu J, Ji A, Wang X, Zhu Y, Yu Y, Lin Y,
Liu Y, Li S, Liang Z, Xu X, et al: MicroRNA-195-5p a new regulator
of Fra-1, suppresses the migration and invasion of prostate cancer
cells. J Transl Med. 13:2892015. View Article : Google Scholar
|
|
17
|
Almeida MI, Silva AM, Vasconcelos DM,
Almeida CR, Caires H, Pinto MT, Calin GA, Santos SG and Barbosa MA:
MiR-195 in human primary mesenchymal stromal/stem cells regulates
proliferation, osteogenesis and paracrine effect on angiogenesis.
Oncotarget. 7:7–22. 2016. View Article : Google Scholar :
|
|
18
|
Wu SC, Yang JC, Rau CS, Chen YC, Lu TH,
Lin MW, Tzeng SL, Wu YC, Wu CJ and Hsieh CH: Profiling circulating
MicroRNA expression in experimental sepsis using cecal ligation and
puncture. PLoS One. 8:e779362013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Price NL, Gomes AP, Ling AJ, Duarte FV,
Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro
JS, et al: SIRT1 is required for AMPK activation and the beneficial
effects of resve-ratrol on mitochondrial function. Cell Metab.
15:675–690. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao R, Ma Z, Hu Y, Chen J, Shetty S and Fu
J: Sirt1 restrains lung inflammasome activation in a murine model
of sepsis. Am J Physiol Lung Cell Mol Physiol. 308:L847–L853. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li T, Zhang J, Feng J, Li Q, Wu L, Ye Q,
Sun J, Lin Y, Zhang M, Huang R, et al: Resveratrol reduces acute
lung injury in a LPS-induced sepsis mouse model via activation of
Sirt1. Mol Med Rep. 7:1889–1895. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Opal S, Ellis JL, Suri V, Freudenberg JM,
Vlasuk GP, Li Y, Chahin AB, Palardy JE, Parejo N, Yamamoto M, et
al: Sirt1 activation markedly alters transcription profiles and
improves outcome in experimental sepsis. Shock. 28:559–567.
2015.
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Prola A, Pires Da Silva J, Guilbert A,
Lecru L, Piquereau J, Ribeiro M, Mateo P, Gressette M, Fortin D,
Boursier C, et al: SIRT1 protects the heart from ER stress-induced
cell death through eIF2α deacetylation. Cell Death Differ.
24:343–356. 2017. View Article : Google Scholar
|
|
25
|
Djoumerska-Alexieva I, Pashova S, Vassilev
T and Pashov A: The protective effect of modified intravenous
immunoglobulin in LPS sepsis model is associated with an increased
IRA B cells response. Autoimmun Rev. 12:653–656. 2013. View Article : Google Scholar
|
|
26
|
Paunel-Görgülü A, Flohé S, Scholz M,
Windolf J and Lögters T: Increased serum soluble Fas after major
trauma is associated with delayed neutrophil apoptosis and
development of sepsis. Critical Care. 15:R202011. View Article : Google Scholar :
|
|
27
|
Cai B, Deitch EA and Ulloa L: Novel
insights for systemic inflammation in sepsis and hemorrhage. Med
Inflamm. 2010:6424622010. View Article : Google Scholar
|
|
28
|
Kingsley SMK and Bhat BV: Role of
microRNAs in sepsis. Inflamm Res. 66:1–17. 2017. View Article : Google Scholar
|
|
29
|
Zheng D, Yu Y, Li M, Wang G, Chen R, Fan
GC, Martin C, Xiong S and Peng T: Inhibition of MicroRNA 195
prevents apoptosis and multiple-organ injury in mouse models of
sepsis. J Infect. 213:1661–1670. 2016. View Article : Google Scholar
|
|
30
|
Liu TF, Vachharajani V, Millet P,
Bharadwaj MS, Molina AJ and Mccall CE: Sequential actions of
SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication
during immunometabolic adaptation to acute inflammation and sepsis.
J Biol Chem. 290:396–408. 2015. View Article : Google Scholar :
|
|
31
|
Vachharajani VT, Liu T, Brown CM, Wang X,
Buechler NL, Wells JD, Yoza BK and Mccall CE: SIRT1 inhibition
during the hypoinflammatory phenotype of sepsis enhances immunity
and improves outcome. J Leuk Biol. 96:785–796. 2014. View Article : Google Scholar
|
|
32
|
Zhou Q, Han LR, Zhou YX and Li Y: MiR-195
suppresses cervical cancer migration and invasion through targeting
smad3. Int J Gynecol Cancer. 26:817–824. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li B and Wang S and Wang S: MiR-195
suppresses colon cancer proliferation and metastasis by targeting
WNT3A. Mol Genet Genomics. 293:1245–1253. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu H, Yang Y, Wang Y, Li J, Schiller PW
and Peng T: MicroRNA-195 promotes palmitate-induced apoptosis in
cardiomyocytes by down-regulating Sirt1. Cardiovasc Res. 92:75–84.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Z, Gu H, Lu G, Xu Y, Fei F, Saeed M
and Chao S: Reducing Smad3/ATF4 was essential for Sirt1 inhibiting
ER stress-induced apoptosis in mice brown adipose tissue.
Oncotarget. 8:9267–9279. 2016.PubMed/NCBI
|
|
36
|
Koga T, Suico MA, Shimasaki S, Watanabe E,
Kai Y, Koyama K, Omachi K, Morino-Koga S, Sato T, Shuto T, et al:
Endoplasmic reticulum (ER) stress induces sirtuin 1 (SIRT1)
expression via the PI3K-Akt-GSK3β signaling pathway and promotes
hepatocellular injury. J Biol Chem. 290:30366–30374. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Prola A, Silva JP, Guilbert A, Lecru L,
Piquereau J, Ribeiro M, Mateo P, Gressette M, Fortin D, Boursier C,
et al: SIRT1 protects the heart from ER stress-induced cell death
through eIF2α deacetylation. Cell Death. 24:343–356. 2016.
View Article : Google Scholar
|
